Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Ipilimumab × Clear all

NCT02681302 2025-07-25

CPIT001

Phase 1/2 Terminated

46 enrolled 13 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT04635735 2023-03-23

Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

3 enrolled 5 charts

Multiple Myeloma